FILE- Former French President Nicolas Sarkozy leaves after a Paris court sentenced him to 5 years after finding him guilty of ...

FDA has accepted Replimune’s RP1 resubmission for advanced melanoma treatment. ・Prescription Drug User Fee Act decision date ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the release of toxic granules – ...

This draft illustration is from the cover art of the chapter that kicked off the iconic saga in the Dragon Ball manga.

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Health officials in Los Angeles County said on Friday they are investigating a possible local spread of a more severe strain ...